News Sentiment

RAC sentiment intelligence

Racura Oncology Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 53 Balanced news tone 24 relevant articles

Exchange ASX Australia

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 2.19 Week of 10 Jul 2026

Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

92/100 classification confidence.

Company focus 24

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-4.4% over one week, -8.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Racura Oncology (ASX:RAC) Edges Higher: Could This ASX Cancer-Therapy Stock Be One to Watch?

Market Reaction

Price moving ahead of tone

66/100 confidence

Primary event Market update 92/100 classification

One-week reaction -4.4% Price reacting lower

Trend fit Trend inactive -8.8% over four weeks

Fair value 30.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 4

Neutral 20

Negative 0

Relevance

Why the article matched

Direct first

Direct company coverage 24

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Kalkine 8

The Australian 4

intelligentinvestor.com.au 4

Proactive financial news 3

Stocks Down Under 1

thebull.com.au 1

Market source 1

simplywall.st 1

Event Lens

What the news is about

Classified themes

Market update 22

Regulatory and legal 1

Balance sheet 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-24 of 24

Kalkine Direct company coverage

Racura Oncology (ASX:RAC) Edges Higher: Could This ASX Cancer-Therapy Stock Be One to Watch?

Tone: Positive 66/100
Event: Market update
Published: 13 Jul 2026 07:13
Source: Kalkine

Kalkine Direct company coverage

Racura Oncology (ASX:RAC) Draws Investor Interest Amid Recent Developments

Tone: Neutral 50/100
Event: Market update
Published: 22 Jun 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Race Oncology (ASX:RAC): Oncology Stock Commands Huge Market Interest After $34.3m Raising

Tone: Neutral 50/100
Event: Market update
Published: 19 Jun 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Kalkine ASX Spotlight: What Weighed on Race Oncology (ASX:RAC) Shares Today?

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Racura Oncology Quotes 526,315 New Ordinary Shares at $1.90 Following Placement

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Kalkine

Kalkine Direct company coverage

Racura Oncology (ASX:RAC) Strengthens Funding Position for RC220 Clinical Program

Tone: Neutral 50/100
Event: Market update
Published: 04 Jun 2026 07:00
Source: Kalkine

Stocks Down Under Direct company coverage

Racura Oncology (ASX:RAC) Surges 8% as RC220 Trial Cleared to Double Dosage Level

Tone: Positive 66/100
Event: Market update
Published: 18 May 2026 07:00
Source: Stocks Down Under

Kalkine Direct company coverage

Should Racura Oncology (ASX:RAC) Be on Your Watchlist?

Tone: Neutral 50/100
Event: Market update
Published: 13 May 2026 07:00
Source: Kalkine

The Australian Direct company coverage

Long Shortz with Racura: Tackling MYC-driven cancer pathways

Tone: Neutral 50/100
Event: Market update
Published: 07 Apr 2026 07:00
Source: The Australian

Proactive financial news Direct company coverage

Racura Oncology: Lung Cancer trial targets resistance - ASX SMIDcaps Conference

Tone: Neutral 50/100
Event: Market update
Published: 26 Mar 2026 07:00
Source: Proactive financial news

The Australian Direct company coverage

Racura hits CPACS trial milestone

Tone: Neutral 50/100
Event: Market update
Published: 20 Mar 2026 07:00
Source: The Australian

thebull.com.au Direct company coverage

Racura Oncology Shares Move Positive YTD on RC220 Milestone

Tone: Positive 66/100
Event: Market update
Published: 19 Mar 2026 07:00
Source: thebull.com.au

Kalkine Direct company coverage

Why Racura Oncology (ASX:RAC) Stock Is Surging 10% Today: Cancer Drug Catalysts Driving Rally

Tone: Neutral 50/100
Event: Market update
Published: 19 Mar 2026 07:00
Source: Kalkine

The Australian Direct company coverage

Racura receives governance approval for trial.

Tone: Neutral 50/100
Event: Regulatory and legal
Published: 17 Mar 2026 07:00
Source: The Australian

The Australian Direct company coverage

2026: The road ahead with Racura Oncology

Tone: Neutral 50/100
Event: Market update
Published: 17 Feb 2026 08:00
Source: The Australian

Proactive financial news Direct company coverage

Racura secures $3.2M for lung cancer trial - ICYMI

Tone: Neutral 50/100
Event: Market update
Published: 12 Dec 2025 08:00
Source: Proactive financial news

Proactive financial news Direct company coverage

Race Oncology changes name to Racura Oncology as HARNESS-1 trial gains momentum

Tone: Positive 66/100
Event: Market update
Published: 10 Dec 2025 08:00
Source: Proactive financial news

intelligentinvestor.com.au Direct company coverage

Racura Oncology Ltd (ASX:RAC)

Tone: Neutral 50/100
Event: Market update
Published: 09 Dec 2025 11:14
Source: intelligentinvestor.com.au

intelligentinvestor.com.au Direct company coverage

Racura Oncology Ltd (ASX: RAC) - Share Price

Tone: Neutral 50/100
Event: Market update
Published: 09 Dec 2025 11:14
Source: intelligentinvestor.com.au

Market source Direct company coverage

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Tone: Neutral 50/100
Event: Balance sheet
Published: 11 Nov 2025 08:00
Source: Market source

simplywall.st Direct company coverage

Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?

Tone: Neutral 50/100
Event: Market update
Published: 21 Sep 2025 07:00
Source: simplywall.st

intelligentinvestor.com.au Direct company coverage

Racura Oncology Ltd (ASX: RAC) - Dividends

Tone: Neutral 50/100
Event: Market update
Published: 03 Oct 2019 10:55
Source: intelligentinvestor.com.au

intelligentinvestor.com.au Direct company coverage

Racura Oncology Ltd (ASX: RAC) - Announcements

Tone: Neutral 50/100
Event: Market update
Published: 30 Sep 2019 15:39
Source: intelligentinvestor.com.au

TradingView Direct company coverage

RAC Stock Price and Chart — ASX:RAC

Tone: Neutral 50/100
Event: Market update
Published: 02 Aug 2017 11:35
Source: TradingView